383 related articles for article (PubMed ID: 30200991)
1. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
[TBL] [Abstract][Full Text] [Related]
2. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
Notta D; Black B; Chu T; Joe R; Lysyshyn M
Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
[TBL] [Abstract][Full Text] [Related]
3. Use of rapid fentanyl test strips among young adults who use drugs.
Krieger MS; Goedel WC; Buxton JA; Lysyshyn M; Bernstein E; Sherman SG; Rich JD; Hadland SE; Green TC; Marshall BDL
Int J Drug Policy; 2018 Nov; 61():52-58. PubMed ID: 30344005
[TBL] [Abstract][Full Text] [Related]
4. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L
Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241
[TBL] [Abstract][Full Text] [Related]
5. Rigidity, dyskinesia and other atypical overdose presentations observed at a supervised injection site, Vancouver, Canada.
Kinshella MW; Gauthier T; Lysyshyn M
Harm Reduct J; 2018 Dec; 15(1):64. PubMed ID: 30577844
[TBL] [Abstract][Full Text] [Related]
6. Drug checking as a potential strategic overdose response in the fentanyl era.
Laing MK; Tupper KW; Fairbairn N
Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
[TBL] [Abstract][Full Text] [Related]
7. Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis.
Baldwin N; Gray R; Goel A; Wood E; Buxton JA; Rieb LM
Drug Alcohol Depend; 2018 Apr; 185():322-327. PubMed ID: 29486421
[TBL] [Abstract][Full Text] [Related]
8. Expanding harm reduction to include fentanyl urine testing: results from a pilot in rural British Columbia.
Mema SC; Sage C; Popoff S; Bridgeman J; Taylor D; Corneil T
Harm Reduct J; 2018 Apr; 15(1):19. PubMed ID: 29625621
[TBL] [Abstract][Full Text] [Related]
9. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
[TBL] [Abstract][Full Text] [Related]
10. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.
Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE
Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493
[TBL] [Abstract][Full Text] [Related]
11. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
[TBL] [Abstract][Full Text] [Related]
12. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.
Fairbairn N; Coffin PO; Walley AY
Int J Drug Policy; 2017 Aug; 46():172-179. PubMed ID: 28687187
[TBL] [Abstract][Full Text] [Related]
13. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
[TBL] [Abstract][Full Text] [Related]
14. Motivators of and barriers to drug checking engagement in British Columbia, Canada: Findings from a cross-sectional study.
Tobias S; Ferguson M; Palis H; Burmeister C; McDougall J; Liu L; Graham B; Ti L; Buxton JA
Int J Drug Policy; 2024 Jan; 123():104290. PubMed ID: 38101275
[TBL] [Abstract][Full Text] [Related]
15. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
Borden SA; Saatchi A; Vandergrift GW; Palaty J; Lysyshyn M; Gill CG
Drug Alcohol Rev; 2022 Feb; 41(2):410-418. PubMed ID: 34347332
[TBL] [Abstract][Full Text] [Related]
16. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips.
Lockwood TE; Vervoordt A; Lieberman M
Harm Reduct J; 2021 Mar; 18(1):30. PubMed ID: 33750405
[TBL] [Abstract][Full Text] [Related]
17. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T
PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391
[TBL] [Abstract][Full Text] [Related]
18. At-a-glance - Supervised Injection Services: a community-based response to the opioid crisis in the City of Ottawa, Canada.
DelVillano S; de Groh M; Morrison H; Do MT
Health Promot Chronic Dis Prev Can; 2019 Mar; 39(3):112-115. PubMed ID: 30869474
[TBL] [Abstract][Full Text] [Related]
19. Investigating opioid preference to inform safe supply services: A cross sectional study.
Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
[TBL] [Abstract][Full Text] [Related]
20. Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl.
Carpenter J; Murray BP; Atti S; Moran TP; Yancey A; Morgan B
J Med Toxicol; 2020 Jan; 16(1):41-48. PubMed ID: 31471760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
